[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"mood-disorder-depressive-episodes\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:mood-disorder-depressive-episodes":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100599658","efficacy-of-remote-monitoring-in-patients-treated-for-moderate-to-severe-major-depressive-episodes-100599658",false,"NCT07087353","Efficacy of Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive Episodes","A Randomized Controlled Trial Assessing the Efficacy of Remote Patient Monitoring in Patients Treated for a Moderate to Severe Major Depressive Episode","EC-102","Inclusion Criteria:\n\n* Adults (≥18 years old) meeting ICD-11 criteria for a moderate to severe major depressive episode\n* Access to a personal smartphone and an internet connection, and cognitively able to use it independently\n\nExclusion Criteria:\n\n* Pregnant women\n* Individuals under legal guardianship or conservatorship\n* Ongoing alcohol or drug abuse considered likely to interfere with study participation, as judged by the investigator\n* Psychiatric or physical comorbidities (e.g., severe neurological or cardiovascular conditions) considered likely to interfere with participation or study results, at the discretion of the Principal Investigator","ALL","18 Years",{"count":20,"type":21},594,"ESTIMATED","INTERVENTIONAL",[24],"NA","Mood disorders like depression and bipolar disorder are widespread and cause serious psychological, cognitive, and social impairments, with a high burden on healthcare systems. Edra PRO is a digital medical device developed to support clinical decision-making and remotely monitor symptoms in psychiatric patients. The EC-102 randomized controlled trial will evaluate its impact compared to usual care on symptoms, quality of life, healthcare costs, comorbidities, and user adherence and satisfaction.",[27],"Mood Disorder (Depressive Episodes)","RECRUITING","2026-04-27",{"date":31,"type":32},"2026-05-01","ACTUAL",{"date":34,"type":32},"2025-10-31",{"date":36,"type":21},"2027-12-01",{"name":38,"class":39},"Resilience","INDUSTRY",6]